Het belang van de patiënten staat voorop

Home / Dr. Paul Cornes

Dr. Paul Cornes

Dr Paul Cornes, MD, PhD, Consultant Oncologist, Bristol, United Kingdom

Dr Paul CORNES 2018 P1130080
Recent Publications
  1. Paul Cornes P, Vulto AG, Jurczak W. Biosimilars for haematologic malignancies: the path to sustainable care. European Med Journal, 8 August 2017. https://emj.europeanmedical-group.com/wp-content/uploads/sites/2/2017/08/Biosimilars-for-Haematologic-Malignancies-The-Path-to-Sustainable-Care.pdf. Accessed March 19, 2018
  2. Cornes P, Muenzberg M. Biosimilars: the challenges to bring a “new” concept to market A short review of the first decade of biosimilars. Parma Horizon 2017;1(2):30-34
  3. Thomas Dörner, Vibeke Strand, Paul Cornes et al. The changing landscape of biosimilars in rheumatology. Ann Rheum Dis 2016;0:1–9. doi:10.1136/annrheumdis-2016-209166
  4. Cornes P. Introducing Biosimilars to Expand Patient Access to Care. EMJ european medical journal. 2014 July:35-39. Accessed Oct 1, 2015
  5. Joerg Windisch, Steffen Thirstrup, Wojciech Jurczak, Paul Cornes. Biosimilars in hematology: increasing choice, expanding access. EMJ European Medical Journal - Haematology. 2014;July:30-39

Nadere informatie

 

 

Wilt u dit delen via: